Download PDF

Other users also viewed these articles

Secondary thrombotic microangiopathy and eculizumab: A reasonable therapeutic option Elena Román, Santiago Mendizábal, Isidro Jarque, Javier de la Rubia, Amparo Sempere, Enrique Morales, Manuel Praga, Ana Ávila, José Luis Górriz
10.1016/j.nefroe.2017.08.001
Nephrotic syndrome as a manifestation of thrombotic microangiopathy due to long-term use of sunitinib John Fredy Nieto-Ríos, Camilo Andrés García-Prada, Arbey Aristizabal-Alzate, Gustavo Zuluaga-Valencia, Dahyana Cadavid-Aljure, Lina Maria Serna-Higuita, Luis F. Arias
10.1016/j.nefroe.2023.02.004
Ravulizumab as an alternative for gemcitabine related trombotic microangiopathy: A case report Cristina Riaza Ortiz, Marta Calvo Arévalo, Marta Álvarez Nadal, Antonio Casado, Ana I. Sánchez-Fructuoso, Clara García-Carro
10.1016/j.nefroe.2025.501356